DERMACOOL

K990417 · Optomed Corp. · GEX · Apr 14, 1999 · General, Plastic Surgery

Device Facts

Record IDK990417
Device NameDERMACOOL
ApplicantOptomed Corp.
Product CodeGEX · General, Plastic Surgery
Decision DateApr 14, 1999
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 878.4810
Device ClassClass 2
AttributesTherapeutic

Intended Use

DermaCool™ is intended for use with a laser or light source utilized for photo-coagulation of dermatological lesions and is a cooling device indicated for: 1. The reduction of pain, 2. Less discomfort, 3. Cooling of the skin prior, during and after laser or light treatment.

Device Story

DermaCool™ is a skin-cooling accessory for laser or light-based dermatological systems. The device utilizes a cooled sapphire window or lens that contacts the patient's skin. Operated by a clinician in a clinical setting, the device provides thermal regulation to the treatment site. By cooling the skin before, during, and after laser exposure, the device reduces patient pain and discomfort associated with dermatological procedures like hair removal or lesion photo-coagulation. The device is a passive cooling interface rather than an active electronic system.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Accessory to laser system; features a sapphire window/lens for skin contact cooling. Passive cooling mechanism. No electronic energy source or software components described.

Indications for Use

Indicated for patients undergoing laser or light-based dermatological procedures (e.g., photo-coagulation of lesions, hair removal) to reduce pain and discomfort via skin cooling before, during, and after treatment.

Regulatory Classification

Identification

(1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.

Predicate Devices

Reference Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ ## APPENDIX VII ## 510(k) summary of Safety and Effectiveness Submitter: OptoMed, Inc. > 13091 Pond Springs Road Austin, TX 78729 - I. Classification: Class II - II. Common or usual name: Accessory to laser system - III. Proprietary Name: DermaCool™ - IV. Registration No.: 1645461 - V. Classification Name: Accessory to laser system, powered, 79GEX, CFR 878-4810, Class II. - VI. Performance standards: None established (as a medical device) under section 514. - DermaCool™ is a skin-cooling device designed for lasers or VII. Description: light sources, which are used for skin treatment applications such as vascular lesions or hair removal. A piece of cooled sapphire window, or lens, which comes in contact with skin, performs skin cooling. - VIII. Labels and Labeling: Labels and Instructions for Use are provided. Competitive labels and labeling are provided and the products are compared. - IX. Indications for Use: DermaCool™ is intended for use with a laser or light source utilized for photo-coagulation of dermatological lesions and is a cooling device indicated for: - 1. The reduction of pain, - 2. Less discomfort, - 3. Cooling of the skin prior, during and after laser or light treatment. - The DermaCoolTM is substanially equilvalent to X. Substantial Equivalence: laser accessories cleared by Candela under K974381 as a laser accessory, and under K951033 as a pack, hot or cold. It is also equivalent to Cool Laser Optics, Inc. CLO Cool Wand, Cool Bag, and CLO Recirculating Slim Pack which do not appear to have 510(k) clearance. The "510(k) Substantial Equivalence Decision-making Process (Detailed) from ODE Guidance Memorandum #86-3 was followed. {1}------------------------------------------------ Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three stripes forming its body and wing. The eagle's head is facing left, and its body is curved. The logo is surrounded by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" in a circular arrangement. Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 APR 1 4 1399 Shahriar Ghaffari, Ph.D. President OptoMed. Inc. 13091 Pond Spring Road Austin, Texas 78729 K990417 Re: Trade Name: DermaCool™ System and Handpiece Regulatory Class: II Product Code: GEX Dated: February 3, 1999 Received: February 10, 1999 Dear Dr. Ghaffari: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (OS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (OS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. {2}------------------------------------------------ ## Page 2 - Shahriar Ghaffari, Ph.D. This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ Page_44of_61 990417 510(k) Number (if known):__ Device Name: DermaCoo1 System and Handpieces Indications For Use: DermaCool is intended for use with a laser or light source utilized for photo-coagulation of dermatological lesions and is a cooling device indicated for: ' - 1. The reduction of pain, - 2. . Less discomfort, - 3. Cooling of the skin prior, during and after laser or light treatment. ## (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) tacoella (Division Sign-Off) Division of General Restorative Devices K990417 510(k) Number **Prescription Use** (Per 21 CFR 801.109) OR Over-The-Counter Use_ (Optional Format 1-2-96)
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...